• 5/6/24

RRP Patient Meeting 2023: Scientific Conference Outcomes and Updates

Dr. Katrin Ericson, RUNX1 Research Program, and Dr. Nancy Speck, University of Pennsylvania, share an overview of the exciting research findings presented at RRP's 2023 Virtual RUNX1 Scientific Conference.

2024 X-Out Cancer Workshop

RUNX1 Attenuates Toll-Like Receptor and Type I Interferon Signaling in Neutrophils

You Might Also Like

Related Embedded Video Item Thumbnail "Mechanisms underlying aging associated increased heterogeneity and selection for clonal hematopoiesis mutations in hematopoietic stem cell pools."
Related Embedded Video Item Thumbnail The Manch Family
Related Embedded Video Item Thumbnail Hematopoietic stem cell division is governed by distinct RUNX1 binding partners
Related Embedded Video Item Thumbnail RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency
Related Embedded Video Item Thumbnail Hereditary Hematologic Malignancies: Not That Rare - Dr. Courtney DiNardo